Is Gilead Sciences Stock a Buy Now?

Valuations in the stock market are sky-high, but it's possible to find companies that are reasonably priced. Biotech giant Gilead Sciences (NASDAQ: GILD) is a good example. It is trading at a mere 8.5 times forward earnings, compared to the average of 10.4 in the industry.

But attractive valuation metrics alone aren't enough to make a stock a buy; it's essential to consider the fundamentals of the business, too. With that in mind, let's look into what's going on with Gilead Sciences right now and whether it is worth purchasing its shares. 

Continue reading

Source Fool.com